Full Text
Full Text PDF
Abstract
Background: One-third of all extraintestinal manifestations are mucocutaneous findings in patients with Crohn’s disease and there is a relationship between some risk factors. Our aim is to evaluate factors associated with mucocutaneous manifestations in our cohort of patients with Crohn’s disease with a follow-up duration of up to 25 years. Methods: In the study, 336 patients with Crohn’s disease who were followed up between March 1986 and October 2011 were included. The demographic characteristics, Crohn’s disease-related data, and accompanying mucocutaneous manifestations were recorded. The cumulative probability of mucocutaneous extraintestinal manifestations and possible risk factors were analyzed. Results: Oral and skin involvement were detected in 109 (32%) and 31 (9.2%) patients, respectively. The cumulative probability of developing oral and skin manifestations were 43.2% and 20.3%, respectively. Cox regression analysis showed that female gender (odds ratio: 3.28, 95% CI: 1.51-7.14, P = .003) and corticosteroid use (odds ratio: 7.88, 95% CI: 1.07-57.97, P = .043) are independently associated with the development of skin manifestations, while family history (odds ratio: 3.59, 95% CI: 2.18-5.93, P < .001) and inflammatory-type disease (odds ratio: 1.776, 95% CI: 1.21-2.61, P = .004) were independently associated with the development of oral ulcers. Conclusion: Mucocutaneous extraintestinal manifestations are associated with female gender, corticosteroid use, family history, and disease type in a large cohort of patients with Crohn’s disease. Defining the specific relationships of immune-mediated diseases will help to better understand the pathogenesis of Crohn’s disease and associated mucocutaneous manifestations and to use more effective treatments. Cite this article as: Kayar Y, Dertli R, Konür S, et al. Mucocutaneous manifestations and associated factors in patients with Crohn’s disease. Turk J Gastroenterol. 2022;33(11):945-954.
Most read articles by the same author(s)
- Merve Guzel Dirim, Asli Cifcibasi Ormeci, Bilger Cavus, Arzu Poyanli, Kursat Rahmi Serin, Filiz Akyuz, Kadir Demir, Selman Fatih Besisik, Sabahattin Kaymakoglu, Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study , Turkish Journal of Gastroenterology: Vol. 36 No. 4 (2025): Turkish Journal of Gastroenterology
- Ummu Mutlu, Sezen Genc Ulucecen, Raim Iliaz, Alp Atasoy, Bilger Cavus, Asli Ciftcibasi Ormeci, Filiz Akyuz, Kadir Demir, Sabahattin Kaymakoglu, Fatih Besisik, Intra-Abdominal Hypertension and Its Prognostic Impact on Mortality in Cirrhotic Patients with Ascites: The Role of Paracentesis , Turkish Journal of Gastroenterology: Vol. 36 No. 6 (2025): Turkish Journal of Gastroenterology
- Murat Törüner, İsmail Hakkı Kalkan, Filiz Akyüz, Ahmet Tezel, Aykut Ferhat Çelik, Turkish IBD Organization’s Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic , Turkish Journal of Gastroenterology: Vol. 32 No. 6 (2021): Turkish Journal of Gastroenterology
- Dilek Oğuz, İsmail Hakkı Kalkan, Müjde Soytürk, Kadir Demir, Nevin Oruç, Göksel Bengi, Özlem Gül, Nalan Gülşen Ünal, Aslı Çiftibaşı Örmeci, Validity and Diagnostic Ability of Pancreatic Exocrine Insufficiency Questionnaire in Turkish Patients , Turkish Journal of Gastroenterology: Vol. 35 No. 9 (2024): Turkish Journal of Gastroenterology
- Mukaddes Tozlu, Yusuf Kayar, Ali Tüzün İnce, Birol Baysal, Hakan Şentürk, Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled,open-label study , Turkish Journal of Gastroenterology: Vol. 30 No. 1 (2019): Turkish Journal of Gastroenterology
- Ramazan Dertli, Mehmet Asil, A Critical Perspective on Helicobacter pylori Treatment Strategies: Are Levofloxacin-Based Regimens Truly Suitable as First-Line Therapy? , Turkish Journal of Gastroenterology: Vol. 37 No. 6 (2026): Turkish Journal of Gastroenterology
- Erman Aytaç, Leyla Özer, Bilgi Baca, Emre Balık, Yersu Kapran, Orhun Cığ Taşkın, Başak Oyan Uluç, Mehmet Ufuk Abacıoğlu, Murat Gönenç, Yasemin Bölükbaşı, Barbaros E. Çil, Bülent Baran, Cem Aygün, Mehmet Erdem Yıldız, Kemal Ünal, Burçak Erkol, Tunç Yaltı, Uğur Özbek, Tan Attila, Nurdan Tözün, Bengi Gürses, Sibel Erdamar, Özlem Er, Nuran Beşe, Orhan Bilge, Güralp Onur Ceyhan, Nil Molinas Mandel, Uğur Selek, Cengiz Yakıcıer, Hülya Kayserili Karabey, Murat Saruç, Volkan Özben, Eren Esen, Emre Özoran, Erkan Vardareli, Levent Güner, İsmail Hamzaoğlu, Dursun Buğra, Tayfun Karahasanoğlu, The İstanbul Group, Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement , Turkish Journal of Gastroenterology: Vol. 33 No. 8 (2022): Turkish Journal of Gastroenterology
- Sami Evirgen, Raim İliaz, Filiz Akyüz, Bilger Çavuş, Suut Göktürk, Aslı Örmeci, Özlem Mutluay Soyer, Bülent Baran, Binnur Pınarbaşı, Çetin Karaca, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu, Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center , Turkish Journal of Gastroenterology: Vol. 33 No. 6 (2022): Turkish Journal of Gastroenterology
- Ozan Durmaz, Adnan Ozkahraman, Yusuf Kayar, Rare Side Effect Due to Vedolizumab in a Patient with Ulcerative Colitis: Catatonic Depression , Turkish Journal of Gastroenterology: Vol. 37 No. 1 (2026): Turkish Journal of Gastroenterology
- Raim İliaz, Filiz Akyüz, Gülçin Yeğen, Aslı Örmeci, Suut Göktürk, Ümit Akyüz, Bülent Baran, Özlem Mutluay, Sami Evirgen, Çetin Karaca, Kadir Demir, Fatih Beşışık, Mine Güllüoğlu, Sabahattin Kaymakoğlu, Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? , Turkish Journal of Gastroenterology: Vol. 29 No. 4 (2018): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 33 · Issue 11
Pages
945-954
History
Published Online
November 15, 2022
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Copyright (c) 2022 Yusuf Kayar, Ramazan Dertli, Şevki Konür, Mehmet Ağın, Abdullah Al Kafee, Bülent Baran, Aslı Çiftçibaşı Örmeci, Filiz Akyüz, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu
Affiliations
Yusuf Kayar
Department of Internal Medicine, Division of Gastroenterology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey
Ramazan Dertli
Department of Internal Medicine, Division of Gastroenterology, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey
Şevki Konür
Department of Internal Medicine, Van Teaching and Research Hospital, Health Sciences University, Van, Turkey
Mehmet Ağın
Department of Pediatric Gastroenterology, Çukurova University Medical Faculty, Adana, Turkey
Abdullah Al Kafee
Department of Biomedical Engineering, Fatih University Institute of Biomedical Engineering, İstanbul, Turkey
Bülent Baran
Department of Gastroenterology, Van Region Training and Research Hospital, Van, Turkey
Aslı Çiftçibaşı Örmeci
Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Filiz Akyüz
Covering the Cover Editor
Kadir Demir
İstanbul Üniversitesi, İstanbul Tıp Fakültesi Gastroenteropatoloji Bilim Dalı ve Patoloji anabilim Dalı, İstanbul
Fatih Beşışık
Departments of Gastroenterohepatology, İstanbul University İstanbul Medical Faculty, İstanbul
Sabahattin Kaymakoğlu
Department of Gastroenterology, İstanbul University, İstanbul School of Medicine, İstanbul
Cite this Article
Kayar, Y., Dertli, R., Konür, Şevki, Ağın, M., Al Kafee, A., Baran, B., … Kaymakoğlu, S. (2022). Mucocutaneous Manifestations and Associated Factors in Patients with Crohn’s Disease. Turkish Journal of Gastroenterology, 33(11), 945–954. https://doi.org/10.5152/tjg.2022.21750
Outlines